Annals of Surgical Oncology

, Volume 25, Supplement 3, pp 899–900 | Cite as

ASO Author Reflections: Tegafur–Uracil in Advanced Oral Cancer

  • Ming-Yu Hsieh
  • Mu-Kuan ChenEmail author
ASO Author Reflections



The authors declare that they have no conflicts of interest to disclose.


  1. 1.
    American Cancer Society. Cancer facts & figures 2016. Accessed Jan 2016.
  2. 2.
    Hsieh M-Y, Chen G, Chang D-C, Chien S-Y, Chen M-K. The impact of metronomic adjuvant chemotherapy in patients with advanced oral cancer. Ann Surg Oncol. 2018;25:2091–2097.CrossRefPubMedGoogle Scholar
  3. 3.
    Vermorken JB, Mesia R, Rivera F, et al. Platinum-based chemotherapy plus cetuximab in head and neck cancer. N Engl J Med. 2008;359(11):1116–27.CrossRefPubMedGoogle Scholar
  4. 4.
    Szturz P, Vermorken JB. Immunotherapy in head and neck cancer: aiming at EXTREME precision. BMC Med. 2017;15:110.CrossRefPubMedCentralPubMedGoogle Scholar

Copyright information

© Society of Surgical Oncology 2018

Authors and Affiliations

  1. 1.Department of Otorhinolaryngology-Head and Neck SurgeryChanghua Christian HospitalChanghuaTaiwan

Personalised recommendations